QUOTE AND NEWS
FierceBiotech  Oct 27  Comment 
Icagen's share price was battered this morning after the develop announced that it is shelving its experimental asthma drug, senicapoc, after it failed a mid-stage trial. Icagen shares plunged 42 percent and were trading at 45 cents this...
StreetInsider.com  Oct 26  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/FDA/Icagen+%28ICGN%29+Senicapoc+Fails+In+Phase+IIa+Study/5045129.html for the full story.
StreetInsider.com  Oct 19  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Icagen+%28ICGN%29+Presented+Data+Found+in+Collaboration+with+Pfizer+%28PFE%29+to+Identify+Sodium+Channel+Modulators/5027496.html for the full story.
StreetInsider.com  Sep 28  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/FDA/Icagen+%28ICGN%29+Announces+Proof-of-Mechanism+Study+of+ICA-105665+in+Pain/4973848.html for the full story.
StreetInsider.com  Sep 24  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Icagen+%28ICGN%29+Announces+Initiation+of+Proof-of-Concept+Study+of+ICA-105665/4968195.html for the full story.
FierceBiotech  Sep 1  Comment 
Shares of Research Triangle Park, NC-based Icagen were buoyed this morning on the news that its experimental allergic asthma therapy proved promising in a mid-stage trial. Researchers for the developer say that senicapoc improved every measure...
StreetInsider.com  Sep 1  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/FDA/Icagen+%28ICGN%29+Jumps+On+Positive+Study+Results/4913430.html for the full story.
MarketWatch  Aug 3  Comment 
Drug stocks gain as shares of Icagen rally on news that the Food and Drug Administration is allowing the company to proceed with development of its new therapy for epilepsy.
MarketWatch  Aug 3  Comment 
Stocks making big moves in Monday's U.S. stock market included Barclays, Barnes, Clorox, CNA Financial, Genzyme, and HSBC.
Suggest a News Source
Topic
Top news source/blog that we're missing
Why do you recommend this news source?
Close 
Thanks for your suggestion!
 


 
ICGN AT A GLANCE
 
 
 
 
 
 
 
 




References

Wikinvest © 2006, 2007, 2008, 2009. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki